The effects of methadone and its role in fatalities

Human Psychopharmacology
John M CorkeryAdenekan Oyefeso

Abstract

Methadone is a synthetic opioid, used both as an analgesic in severe pain relief and now mainly in the treatment of opiate dependence. Such use of the drug has increased as its advantages have become widely recognized. There are undesirable outcomes from its greater use, including a substantial market in diverted methadone and a high number of deaths where the drug has been implicated. It is important to understand how and why methadone causes death so that such fatalities can be minimized, and to disseminate such information. This paper presents an overview of the chief effects of methadone on the human body, considering its metabolism, drug interactions and tolerance. The principal mechanisms by which methadone causes death are discussed: respiratory depression, aspiration of vomit, pulmonary oedema, bronchopneumonia, cardiac problems and renal failure. Many such deaths are preventable, if drug interactions and polydrug use are avoided, its longer period of metabolism and individuals' tolerance levels are considered. It is hoped that this paper will (a) help guide health professionals in their management and treatment of patients participating in methadone treatment programmes, and (b) provide some basic information for those...Continue Reading

References

Jun 4, 1977·Lancet·M R Bending, P O Skacel
Jan 1, 1978·Annals of the New York Academy of Sciences·M J Kreek
Feb 1, 1977·Clinical Pharmacology and Therapeutics·G D OlsenN Gerber
May 13, 1976·The New England Journal of Medicine·M J KreekL M Giusti
Dec 1, 1992·The American Journal of Forensic Medicine and Pathology·O H DrummerS M Cordner
Aug 1, 1992·Drug and Alcohol Dependence·N Loimer, R Schmid
Feb 17, 1990·Lancet·C H Wu, J A Henry
Dec 1, 1985·Journal of Applied Physiology·T V Santiago, N H Edelman
Dec 1, 1988·Clinical Pharmacology and Therapeutics·J B SkatrudM A Busch
Sep 1, 1988·Journal of Health and Social Behavior·J C BallS R Friedman
Dec 1, 1986·Anaesthesia·M D WestonJ A Jones
Jan 1, 1987·Journal of Psychosomatic Research·A H Ghodse, J S Myles
Jan 1, 1985·Human Toxicology·P G BlainM D Rawlins
May 1, 1971·The Journal of Pharmacy and Pharmacology·A E Robinson, F M Williams
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·V P Dole, M J Kreek
Aug 1, 1970·The British Journal of Addiction to Alcohol and Other Drugs·R Gardner
Sep 1, 1970·The International Journal of the Addictions·M M Baden
Oct 1, 1984·The American Journal of Psychiatry·S J Liu, R I Wang
Jun 1, 1983·Journal of Toxicology. Clinical Toxicology·A A Nanji, J D Filipenko
Mar 1, 1981·Annals of Internal Medicine·T G TongN L Benowitz
Sep 1, 1981·Clinical Pharmacology and Therapeutics·D M NovickR J Stenger
Jun 1, 1995·The American Journal of Forensic Medicine and Pathology·B LevineJ E Smialek
Sep 10, 1994·BMJ : British Medical Journal·P WilsonG E Ralston
Jan 1, 1993·International Journal of Legal Medicine·K WormB Kringsholm
Feb 1, 1994·Therapeutic Drug Monitoring·G BertschyD Baettig
Jan 1, 1993·Addiction·J R CaplehornV J Gebski
Apr 1, 1993·International Journal of Epidemiology·M DavoliD D Abeni
May 1, 1996·Neuron·E J Nestler
Aug 3, 1996·BMJ : British Medical Journal·A CairnsE W Benbow
Aug 24, 1996·BMJ : British Medical Journal·T J HendraA R Forrest
Jan 1, 1996·Substance Use & Misuse·J R CaplehornJ G Nisbet
Oct 12, 1996·BMJ : British Medical Journal·D RaistrickK Wolff
Nov 14, 1997·British Journal of Clinical Pharmacology·K WolffG T Tucker
Jul 15, 1998·Clinical Pharmacology and Therapeutics·M N CobbP M Rainey
Jan 29, 1999·Lancet·J WardR P Mattick
Mar 5, 1999·The Medical Journal of Australia·J R Caplehorn, O H Drummer

❮ Previous
Next ❯

Citations

Apr 23, 2008·Intensive Care Medicine·Laurens Mitchell HeggsJérôme Fichet
Oct 20, 2009·European Archives of Psychiatry and Clinical Neuroscience·Frank HölscherNorbert Scherbaum
Jan 21, 2010·Journal of General Internal Medicine·Vania Modesto-LoweNancy Petry
Apr 25, 2006·Journal of Palliative Medicine·Elizabeth A Kvale, John L Shuster
Jan 17, 2012·Harm Reduction Journal·Paul Duffy, Helen Baldwin
Mar 21, 2012·Substance Abuse Treatment, Prevention, and Policy·Hsin-Ya LeeHsin-Pei Tang
Oct 12, 2011·Journal of Medical Case Reports·Wenjie J LuDavid A Flockhart
Jan 17, 2007·Critical Care : the Official Journal of the Critical Care Forum·Bruno MégarbaneFrédéric J Baud
Sep 8, 2006·Journal of Addictive Diseases·Anita Srivastava, Meldon Kahan
Nov 10, 2013·PloS One·Tamara AntonioKenneth Alper
Jun 4, 2014·Current Treatment Options in Psychiatry·Jane LiebschutzAllison Lange
Sep 10, 2014·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Charlann Staab
Jun 2, 2006·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Montserrat Neira-LeónUNKNOWN Project Itinere Group
Sep 10, 2014·Journal of Toxicology·Abbas AghabiklooeiBabak Mostafazadeh
Apr 14, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders
Feb 20, 2013·Forensic Science International : Synergy·Jennifer L PilgrimOlaf H Drummer
Aug 4, 2012·Drug and Alcohol Dependence·Jermaine D JonesSandra D Comer
Mar 18, 2011·Heart & Lung : the Journal of Critical Care·Kristin L Thanavaro, Joanne L Thanavaro
Sep 2, 2009·Drug and Alcohol Dependence·Shane DarkeMichelle Torok
Aug 29, 2007·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Louise LambYoram Shir
Oct 7, 2015·Journal of Forensic and Legal Medicine·Jean-Paul BernardJørg Mørland
Dec 21, 2007·Journal of Forensic Sciences·Lisa B E ShieldsDonna Stewart
Jan 25, 2012·Journal of Forensic Sciences·Kenneth R AlperJames R Gill
Jan 16, 2010·Pharmacoepidemiology and Drug Safety·Terry L BunnMichael Singleton
Dec 14, 2006·Expert Opinion on Pharmacotherapy·Jason M White, Olga V Lopatko
Mar 1, 2012·Forensic Science International : Synergy·Benito MorentinAmparo Fernández-Rodríguez
Mar 1, 2011·Pharmacology, Biochemistry, and Behavior·Jannike M AndersenJørg Mørland
Dec 20, 2012·Thérapie·Céline EidenHélène Peyrière
Mar 9, 2007·Palliative Medicine·Rob George, Claud Regnard
Mar 9, 2007·Palliative Medicine·Bassam EstfanLisa Rybicki
May 16, 2014·Journal of Burn Care & Research : Official Publication of the American Burn Association·Helene Retrouvey, Shahriar Shahrokhi
Jun 22, 2013·The Cochrane Database of Systematic Reviews·Pier Paolo PaniMatteo Pacini
Oct 30, 2010·The American Journal of Forensic Medicine and Pathology·Michelle E Madden, Steven L Shapiro
Nov 20, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Wesley D McMillian, Sheila C Gencarelli
Jan 19, 2010·The American Journal of Forensic Medicine and Pathology·Caroline AlbionJames Cairns
Nov 2, 2006·International Journal of Epidemiology·Oliver MorganMatthew Hickman
Oct 25, 2006·Journal of Public Health·O W MorganC Griffiths
Jul 7, 2011·Pediatric Emergency Care·Louis Eugene Daugherty
Mar 2, 2010·The American Journal of Forensic Medicine and Pathology·Michael C LetskyBlaine E Benson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.